Advertisement

Pharmaceutical Chemistry Journal

, Volume 43, Issue 3, pp 130–133 | Cite as

Pharmacokinetics of acetaminophen administered in tablets and capsules under long-term space flight conditions

  • I. V. Kovachevich
  • S. N. Kondratenko
  • A. K. Starodubtsev
  • L. G. Repenkova
Article

The pharmacokinetics of acetaminophen in two medicinal forms, tablets and capsules, have been studied in healthy volunteers after single peroral administration at a dose of 500 mg under usual living conditions and during long-term space flight. The rate of drug absorption from tablets decreases significantly whereas the relative bioavailability increases substantially under microgravity conditions (compared with usual conditions). For the encapsulated medicinal form, the time of absorption decreases statistically reliably and the half-elimination time, the average retention time, and the distribution volume increase considerably whereas the bioavailability changes insignificantly.

Key words

acetaminophen tablets capsules pharmacokinetics space flight 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    A. Bedjaoui, F. Demotes-Mainard, F. Raynal, et al., Therapie, 39, 353 – 359 (1984).PubMedGoogle Scholar
  2. 2.
    M. Divoll, Clin. Pharmacol. Ther., 31(2), 151 – 156 (1982).PubMedGoogle Scholar
  3. 3.
    D. R. Abernethe, Int. J. Clin. Pharmacol. Ther., 32(6), 783 – 790 (1982).Google Scholar
  4. 4.
    E. B. Nelson, Br. J. Clin. Pharmacol., 22, 111 – 113 (1986).PubMedGoogle Scholar
  5. 5.
    M. D. Ravlins, D. B. Henderson, and A. R. Hijat, Eur. J. Clin. Pharmacol., 11(4), 283 – 286 (1977).CrossRefGoogle Scholar
  6. 6.
    V. M. Mikhailov, V. P. Alekseeva, M. P. Kuz_min, et al., Kosm. Biol. Aviakosm. Med., No. 1, 23 – 28 (1979).Google Scholar
  7. 7.
    R. H. Rumble, Clin. Pharmacokinet., 20, 167 – 173 (1991).PubMedCrossRefGoogle Scholar
  8. 8.
    C. Adithan and J. Thangam, Br. J. Clin. Pharmacol., 14, 107 – 109 (1982).PubMedGoogle Scholar
  9. 9.
    S. N. Kondratenko, A. K. Starodubtsev, I. V. Kovachevich, and I. V. Zolkina, in: Proceedings of the International Scientific-Practical Conference Clinical Pharmacology in Russia: Progress and Prospects [in Russian], Moscow (2004), pp. 104 – 106.Google Scholar
  10. 10.
    N. M. Cintron, H. W. Lane, and C. S. Leach, Physiologist, 33(1), 16 – 19 (1990).Google Scholar
  11. 11.
    S. E. O’Connell and F. J. Zurzola, J. Pharm. Sci., 71, 1291 – 1294 (1982).PubMedCrossRefGoogle Scholar
  12. 12.
    A. A. Agafonov and V. K. Piotrovskii, Khim.-farm. Zh., 25(10), 16 – 19 (1991).Google Scholar
  13. 13.
    I. B. Bondareva, V. B. Gerasimov, A. P. Drozhzhin, et al., “Qualitative studies of drug bioequivalency. Methodical instructions,” Moscow (2004).Google Scholar

Copyright information

© Springer Science+Business Media, Inc. 2009

Authors and Affiliations

  • I. V. Kovachevich
    • 1
  • S. N. Kondratenko
    • 2
  • A. K. Starodubtsev
    • 2
  • L. G. Repenkova
    • 1
  1. 1.Institute of Medico-Biological ProblemsRussian Academy of SciencesMoscowRussia
  2. 2.Sechenov Medical AcademyMoscowRussia

Personalised recommendations